Option Care Health (NASDAQ:OPCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Option Care Health (NASDAQ:OPCH - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.35 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.02, Zacks reports. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.29 billion.

Option Care Health Stock Up 0.9 %

Option Care Health stock traded up $0.30 during trading on Friday, reaching $33.50. The stock had a trading volume of 2,381,009 shares, compared to its average volume of 1,800,100. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.17. The business has a 50 day moving average price of $28.70 and a 200 day moving average price of $28.09. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market cap of $5.70 billion, a PE ratio of 28.15, a P/E/G ratio of 2.30 and a beta of 1.35.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on OPCH shares. JMP Securities reiterated a "market outperform" rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their price target for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. UBS Group assumed coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a "neutral" rating and a $26.00 price target for the company. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and lifted their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $32.88.

Remove Ads

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.